Monday, November 29, 2021

Business Intelligence Monitor 211130

(Introduction)

[Markets]


[Indicators]
•   US Nov. Dallas Fed manufacturing Index: Texas Manufacturers Are Boosting Wages as Inflation Pressures Rise
•   Eurozone Nov. Economic sentiment: Euro-Area Economic Confidence Retreats as Consumer Mood Slips
•   Vietnam Nov. Balance of trade: Vietnam Sees Surge in Nov. Exports After End of Lockdowns


[Trackers]
•   Johns Hopkins University: COVID-19 Global Cases & Deaths
•   Worldometer: COVID Live Update
•   Bloomberg: Covid-19 Vaccine Tracker
•   Bloomberg: Global PMI Tracker
•   Bloomberg: The Covid Resilience Ranking


[News]
※   New York City broadens mask advisory, reflecting potential risks posed by new variant
※   President Biden said Monday that his administration was working with officials at Pfizer Inc., Moderna Inc. and Johnson & Johnson to develop contingency plans for vaccines or boosters
※   “This variant is a cause for concern, not a cause for panic,” he said.
※   Testing just started, but drugmakers have expressed concern that Covid-19 vaccines won’t work as well against the new strain
※   Negotiations in Vienna aim to address steps Iran and the U.S. will take to revive the 2015 nuclear deal
※   Mutations can work together to make a virus more fearsome, but they can also cancel one another out. This phenomenon, called epistasis, is why scientists are reluctant to speculate on Omicron.
※   While wind and solar ramp up, several countries, including France and Britain, are looking to expand their nuclear energy programs. Germany and others aren’t so enthusiastic.
※   “The likelihood of potential further spread of Omicron at the global level is high,”
※   Initial assessment based on growing ability of economies worldwide to adapt to Covid waves
※   Brussels wants Global Gateway proposals to help boost its influence worldwide
※   Senate testimony doesn’t discuss tapering of bond purchases
※   The cost of producing green hydrogen with renewable energy is set to fall and the capacity to produce it in Europe and nearby countries will likely surpass current targets by 2030
※   “This is a tool that was available to us and will be available again,”
※   Moderna CEO Stephane Bancel told CNBC that it could take months to develop and ship an omicron specific vaccine, but a higher dose of its booster could be ready much sooner.
※   Industry tries to buy time for fossil fuel plants as pressure to go green mounts


[Opinions]
•   Project Syndicate(Helmut K. Anheier): A More Daring Germany
•   Project Syndicate(Nina L. Khrushcheva): Send Out the Clowns
•   Project Syndicate(Jean Pisani-Ferry): The End of the Economic Consensus
•   Project Syndicate(Hans-Werner Sinn): The End of Free Money
•   FT(Editorial Board): The gap between US spending and confidence
•   FT(Gideon Rachman): Why China’s elite tread a perilous path
•   FT(Robin Wigglesworth): Markets are more fragile than investors think
•   FT(Robert Armstrong): Why junk bond yields are not so absurd
•   FT(Robert Armstrong): Is Omicron different for markets?
•   FT(Mary O'Sullivan): The economic lure of alternative worlds
•   FT(Claire Jones): Is a BoE rate hike off the cards?
•   FT(Jamie Powell): China’s population is shrinking, fast
•   WSJ(James Freeman): Biden’s Partisan Pandemic History
•   WSJ(Thomas J. Duesterberg): The WTO’s Fast Track to Irrelevance
•   Bloomberg(Bobby Ghosh): Iran Shows It Isn’t Serious About Nuclear Talks
•   Nikkei Asia(Peter A. Petri, Michael G. Plummer): Why South Korea should join the CPTPP

No comments:

Post a Comment